SpyGlass Pharma, Inc. Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss
SpyGlass Pharma, Inc. (SGP) had Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss of $11.04 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets
us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss · last filed 2026-08-06
- 2026-06-30: Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss $11.04M.
- 2026-03-31: Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss $12.10M.
- 2025-12-31: Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss $11.08M.
- 2024-12-31: Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss $0.00.
| Period end | Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss |
|---|---|
| 2026-06-30 | $11.04M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $12.10M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $11.08M 10-Q · filed 2026-08-06 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |